Evaluation of Fosmidomycin and Clindamycin When Administered Concurrently to Adult Subjects With Acute Uncomplicated Plasmodium Falciparum Malaria

Trial Profile

Evaluation of Fosmidomycin and Clindamycin When Administered Concurrently to Adult Subjects With Acute Uncomplicated Plasmodium Falciparum Malaria

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 03 Mar 2016

At a glance

  • Drugs Artesunate (Primary) ; Clindamycin (Primary) ; Clindamycin/fosmidomycin (Primary) ; Fosmidomycin (Primary)
  • Indications Falciparum malaria
  • Focus Therapeutic Use
  • Acronyms JP015
  • Sponsors Jomaa Pharma
  • Most Recent Events

    • 03 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top